Impact of ventilation on aerogenic transmission of the coronavirus RIVM has calculated the impact of different ventilation rates on the number of people who become ill due to aerogenic transmission of the coronavirus SARS-CoV-2 in indoor spaces.
RIVM to play greater role in tuberculosis control The Committee for Practical Tuberculosis Control (CPT) will be transferred per 1 January 2022 to the National Institute for Public Health and the Environment (RIVM) after a period of 70 years with KNCV Tuberculosis Foundation.
Significant increase in support for and compliance with coronavirus measures Compliance with coronavirus measures such as working from home, distancing and testing if you have symptoms increased during the recent period of high infection rates and hospital admissions.
New WHO Collaborating Centre hosted by RIVM combines laboratory preparedness and biorisk RIVM has been designated WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk by the World Health Organization (WHO).
Wider availability of self-tests leads to higher willingness to test As of Friday 3 December, the recommendation in the Netherlands is to use a self-test in case of mild symptoms, as an alternative to a test by the Municipal Public Health Services (GGDs). Beeld: ANP
Healthcare utilisation increases with Long COVID symptoms More than 15,000 people are taking part in the LongCOVID study conducted by RIVM. Participants with existing long-term symptoms after COVID-19 (Long COVID) reported higher healthcare utilisation.
Vaccines very effective against hospital and ICU admissions, also for Delta variant COVID-19 vaccines work well in preventing people from being admitted to hospital or ICU for COVID-19, according to a new analysis by RIVM.
COVID-19 vaccination reduces transmission Vaccination against COVID-19 reduces the transmission of the virus from one person to another. This is apparent from RIVM research using data from source and contact tracing by the Municipal Public Health Services (GGDs).
Nearly 85% of people aged 18 and over have had at least one vaccination The RIVM vaccination update this week has been expanded to include three maps of the Netherlands. For the first time, it is now possible to see vaccination turnout by municipality for everyone aged 18 years and over.